Product Information
FLUPHENAZINE 2.5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.2237 per EA under NDC 62135041690. Its NADAC has been published 190 times since Feb 15, 2023.
FDA first approved this application on Oct 20, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135041690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUPHENAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215141FDA Approved
10/20/2021
TE Code
AB
On Market Since
1/1/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUPHENAZINE 2.5 MG TABLET has been published 190 times since Feb 15, 2023, and over the history we have for it it has declined 82.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2237 per EA |
|---|---|
| All-time high | $1.2701 (Mar 15, 2023) |
| All-time low | $0.2046 (Jul 22, 2026) |
| 52-week high | $0.4964 |
| 52-week low | $0.2046 |
| Median price | $0.4256 |
| Average price | $0.5241 |
| Largest weekly change | +57.5% (Jun 21, 2023) |
| Weeks tracked | 190 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluphenazine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUPHENAZINE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUPHENAZINE 2.5 MG TABLET, manufactured by Chartwell RX LLC, is $0.2237 per EA (NDC 62135041690), effective Sep 30, 2026.
How has the price of FLUPHENAZINE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUPHENAZINE 2.5 MG TABLET has declined 82.4%. It has been tracked across 190 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for FLUPHENAZINE 2.5 MG TABLET?
Since Feb 15, 2023, the NADAC for FLUPHENAZINE 2.5 MG TABLET has ranged from a low of $0.2046 (Jul 22, 2026) to a high of $1.2701 (Mar 15, 2023), with a median of $0.4256 per EA.
Are there cheaper alternatives to FLUPHENAZINE 2.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUPHENAZINE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUPHENAZINE 2.5 MG TABLET?
FLUPHENAZINE 2.5 MG TABLET (NDC 62135041690) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.